Last updated: 22 May 2020 at 5:14pm EST

Thomas E. Hughes Net Worth




The estimated Net Worth of Thomas E. Hughes is at least $2.42 Million dollars as of 11 October 2018. Thomas Hughes owns over 10,000 units of Zafgen stock worth over $12,699 and over the last 10 years Thomas sold ZFGN stock worth over $2,406,474.

Thomas Hughes ZFGN stock SEC Form 4 insiders trading

Thomas has made over 11 trades of the Zafgen stock since 2015, according to the Form 4 filled with the SEC. Most recently Thomas bought 10,000 units of ZFGN stock worth $47,700 on 11 October 2018.

The largest trade Thomas's ever made was exercising 93,211 units of Zafgen stock on 11 May 2017 worth over $74,569. On average, Thomas trades about 11,449 units every 49 days since 2015. As of 11 October 2018 Thomas still owns at least 12,827 units of Zafgen stock.

You can see the complete history of Thomas Hughes stock trades at the bottom of the page.



What's Thomas Hughes's mailing address?

Thomas's mailing address filed with the SEC is C/O MIRAGEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER, CO, 80301.

Insiders trading at Zafgen

Over the last 10 years, insiders at Zafgen have traded over $14,218,922 worth of Zafgen stock and bought 689,531 units worth $3,998,442 . The most active insiders traders include James E Deerfield Mgmt L.P...., Bruce Booth, and Kevin P Starr. On average, Zafgen executives and independent directors trade stock every 53 days with the average trade being worth of $87,516. The most recent stock trade was executed by Thomas E. Hughes on 28 June 2018, trading 32,000 units of ZFGN stock currently worth $320,000.



What does Zafgen do?

Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.



What does Zafgen's logo look like?

Zafgen, Inc. logo

Complete history of Thomas Hughes stock trades at Miragen Therapeutics Inc and Zafgen

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
11 Oct 2018 Thomas E. Hughes
Director
Buy 10,000 $4.77 $47,700
11 Oct 2018
12,827
20 Dec 2017 Thomas E. Hughes
Director
Sale 12,000 $8.00 $96,000
20 Dec 2017
2,827
28 Jun 2018 Thomas E. Hughes
Chief Executive Officer
Sale 32,000 $10.00 $320,000
28 Jun 2018
125,247
7 Mar 2018 Thomas E. Hughes
Chief Executive Officer
Sale 5,000 $10.00 $50,000
7 Mar 2018
157,247
11 May 2017 Thomas E. Hughes
Chief Executive Officer
Option 93,211 $0.80 $74,569
11 May 2017
157,371
29 Aug 2016 Thomas E. Hughes
Chief Executive Officer
Buy 10,000 $3.00 $30,000
29 Aug 2016
63,936
22 Jul 2016 Thomas E. Hughes
Chief Executive Officer
Option 25,000 $0.75 $18,750
22 Jul 2016
48,936
8 Jan 2016 Thomas E. Hughes
Chief Executive Officer
Option 10,000 $0.75 $7,500
8 Jan 2016
21,320
8 Jan 2016 Thomas E. Hughes
Chief Executive Officer
Option 10,000 $0.75 $7,500
8 Jan 2016
21,320
23 Sep 2015 Thomas E. Hughes
Chief Executive Officer
Option 10,500 $0.75 $7,875
23 Sep 2015
11,320
17 Sep 2015 Thomas E. Hughes
Chief Executive Officer
Sale 45,626 $42.53 $1,940,474
17 Sep 2015
820


Zafgen executives and stock owners

Zafgen executives and other stock owners filed with the SEC include: